Literature DB >> 12376529

Synergistic activity of the ninth and tenth FIII domains of human fibronectin depends upon structural stability.

Harri Altroff1, Laurence Choulier, Helen J Mardon.   

Abstract

The ninth and tenth FIII domains (FIII9-10) of human fibronectin act in synergy to promote cell adhesion via the interaction with integrin receptors. Here we describe the functional and structural properties of a set of recombinant FIII9-10 mutants containing various alanine substitutions within the key synergistic site, DRVPHSRN in FIII9, either alone or in combination with another substitution (Leu(1408) to Pro), on the opposite face of FIII9, that increases stability and the functional capacity of FIII9-10. We show that the introduction of mutations into the synergistic sequence of FIII9-10 has a negative effect on the adhesion of baby hamster kidney fibroblasts and results in reduced ability of these ligands to recognize integrin alpha(5)beta(1). Conformational stability of the FIII9 domain in the synergy site mutants is likewise reduced in comparison with native FIII9. The Leu(1408) to Pro substitution in mutant FIII9-10 proteins carrying substitutions in the synergy site results in a substantial recovery of the adhesive activity of the mutants and affinity to alpha(5)beta(1). In keeping with the enhancement of functional activity, the Leu(1408) to Pro substitution in the FIII9-10 synergy site mutants also causes a significant increase in conformational stability of FIII9. These observations imply a strong positive correlation between the biological activity and conformational stability of the assessed FIII9-10 mutants and suggest that a Leu(1408) to Pro substitution restores the biological activity of the mutants via their ability to restore their conformational stability. We conclude that domain stability may be a major determinant of the synergistic potential of FIII9. Our data underscore the value of using more than one approach in such structure-function studies and the requirement for validating the global structural integrity of protein ligands in which sequences that disrupt function have been perturbed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376529      PMCID: PMC1626583          DOI: 10.1074/jbc.M209992200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Comparison of the early stages of forced unfolding for fibronectin type III modules.

Authors:  D Craig; A Krammer; K Schulten; V Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

3.  Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin.

Authors:  R P Grant; C Spitzfaden; H Altroff; I D Campbell; H J Mardon
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

4.  Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: comparison with the human fibronectin crystal structure.

Authors:  V Copié; Y Tomita; S K Akiyama; S Aota; K M Yamada; R M Venable; R W Pastor; S Krueger; D A Torchia
Journal:  J Mol Biol       Date:  1998-04-03       Impact factor: 5.469

5.  Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit.

Authors:  A P Mould; J A Askari; S i Aota; K M Yamada; A Irie; Y Takada; H J Mardon; M J Humphries
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

6.  Module-module interactions in the cell binding region of fibronectin: stability, flexibility and specificity.

Authors:  C Spitzfaden; R P Grant; H J Mardon; I D Campbell
Journal:  J Mol Biol       Date:  1997-02-07       Impact factor: 5.469

7.  A comparison of the folding kinetics and thermodynamics of two homologous fibronectin type III modules.

Authors:  K W Plaxco; C Spitzfaden; I D Campbell; C M Dobson
Journal:  J Mol Biol       Date:  1997-08-01       Impact factor: 5.469

8.  2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region.

Authors:  D J Leahy; I Aukhil; H P Erickson
Journal:  Cell       Date:  1996-01-12       Impact factor: 41.582

9.  Cooperative activity of alpha4beta1 and alpha4beta7 integrins in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin through recognition of multiple synergizing binding sites within the central cell-binding domain.

Authors:  Z Yin; E Giacomello; E Gabriele; L Zardi; S Aota; K M Yamada; B Skerlavaji; R Doliana; A Colombatti; R Perris
Journal:  Blood       Date:  1999-02-15       Impact factor: 22.113

10.  Differential activation of focal adhesion kinase, Rho and Rac by the ninth and tenth FIII domains of fibronectin.

Authors:  N A Hotchin; A G Kidd; H Altroff; H J Mardon
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

View more
  11 in total

1.  The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins.

Authors:  Yukimasa Taniguchi; Hiroyuki Ido; Noriko Sanzen; Maria Hayashi; Ryoko Sato-Nishiuchi; Sugiko Futaki; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

2.  Structure of integrin alpha5beta1 in complex with fibronectin.

Authors:  Junichi Takagi; Konstantin Strokovich; Timothy A Springer; Thomas Walz
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

3.  Assay to mechanically tune and optically probe fibrillar fibronectin conformations from fully relaxed to breakage.

Authors:  William C Little; Michael L Smith; Urs Ebneter; Viola Vogel
Journal:  Matrix Biol       Date:  2008-02-21       Impact factor: 11.583

4.  Collective cell migration on artificial extracellular matrix proteins containing full-length fibronectin domains.

Authors:  Eileen Fong; David A Tirrell
Journal:  Adv Mater       Date:  2010-12-07       Impact factor: 30.849

5.  Nanomaterials can dynamically steer cell responses to biological ligands.

Authors:  Ram I Sharma; Jean E Schwarzbauer; Prabhas V Moghe
Journal:  Small       Date:  2010-12-13       Impact factor: 13.281

6.  Solubilization and Purification of α5β1 Integrin from Rat Liver for Reconstitution into Nanodiscs.

Authors:  Estelle Dransart; Aurélie Di Cicco; Ahmed El Marjou; Daniel Lévy; Staffan Johansson; Ludger Johannes; Massiullah Shafaq-Zadah
Journal:  Methods Mol Biol       Date:  2022

7.  Interdomain tilt angle determines integrin-dependent function of the ninth and tenth FIII domains of human fibronectin.

Authors:  Harri Altroff; Robin Schlinkert; Christopher F van der Walle; Andrea Bernini; Iain D Campbell; Jörn M Werner; Helen J Mardon
Journal:  J Biol Chem       Date:  2004-10-12       Impact factor: 5.157

8.  Using self-assembled monolayers to model cell adhesion to the 9th and 10th type III domains of fibronectin.

Authors:  Jessica L Eisenberg; Justin L Piper; Milan Mrksich
Journal:  Langmuir       Date:  2009-12-15       Impact factor: 3.882

9.  Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization.

Authors:  Stephen S J Lee; Vroni Knott; Jelena Jovanović; Karl Harlos; Jonathan M Grimes; Laurence Choulier; Helen J Mardon; David I Stuart; Penny A Handford
Journal:  Structure       Date:  2004-04       Impact factor: 5.006

10.  Interaction of β-sheet folds with a gold surface.

Authors:  Martin Hoefling; Susanna Monti; Stefano Corni; Kay Eberhard Gottschalk
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.